Observational analysis shows that elimusertib impacts body weight in mice with DNA damage response tumors, suggesting side effects may need monitoring.
Supplementary Figure 3. Change in body weight of mice bearing 10 different patient derived xenografts treated with elimusertib 40 mg/kg.
No takes yet. Share an insight, caveat, or question.
Varadarajan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: